Obiltoxaximab SFL
Concentrate for solution for infusion
Compare
|
EU/1/20/1485/001
Authorised: 18/11/2020
SFL Regulatory Services GmbH
|
SPC
PIL
IPAR
|
Obizur
Powder and solvent for solution for injection
Compare
|
EU/1/15/1035/001-003
Baxter Innovations GmbH
|
SPC
PIL
IPAR
EdM
|
Ocaliva
Film-coated tablet
Compare
|
EU/1/16/1139/001
Intercept Pharma Ltd
|
SPC
PIL
IPAR
|
Ocaliva
Film-coated tablet
Compare
|
EU/1/16/1139/002
Authorised: 12/12/2016
Intercept Pharma Ltd
|
SPC
PIL
IPAR
|
Occlusal 26% w/w Cutaneous Solution
Cutaneous solution
Compare
|
PA2325/011/001
Authorised: 19/04/2004
Alliance Pharma (Ireland) Limited
|
SPC
PIL
|
Ocrevus
Concentrate for solution for infusion
Compare
|
EU/1/17/1231/001-002
Roche Registration GmbH
|
SPC
PIL
IPAR
|
Octanate 1000 IU powder and solvent for solution for injection
Powder and solvent for solution for injection
Compare
|
PA2219/004/003
Authorised: 28/11/2014
Octapharma (IP) SPRL
|
SPC
PIL
|
Octanate 250 IU.Powder and solvent for solution for injection
Powder and solvent for solution for injection
Compare
|
PA2219/004/001
Authorised: 04/06/2004
Octapharma (IP) SPRL
|
SPC
PIL
|
Octanate 500 IU powder and solvent for solution for injection
Powder and solvent for solution for injection
Compare
|
PA2219/004/002
Authorised: 28/11/2014
Octapharma (IP) SPRL
|
SPC
PIL
|
Octaplex 1000 IU coagulation factor IX per vial, powder and solvent for solution for infusionHuman Prothrombin Complex
Powder and solvent for solution for infusion
Compare
|
PA2219/005/002
Authorised: 13/11/2015
Octapharma (IP) SPRL
|
SPC
PIL
|
Octaplex 500 IU coagulation factor IX per vial, powder and solvent for solution for infusionHuman Prothrombin Complex
Powder and solvent for solution for infusion
Compare
|
PA2219/005/001
Authorised: 02/07/2004
Octapharma (IP) SPRL
|
SPC
PIL
|
Octreoscan 111 MBq/mL, kit for radiopharmaceutical preparation
Kit for radiopharmaceutical preparation
Compare
|
PA0690/001/001
Authorised: 08/06/1995
Curium Netherlands B.V.
|
SPC
PIL
|
Octreotide 100 micrograms/1 ml solution for injection
Solution for injection
Compare
|
PA0822/218/002
Authorised: 22/06/2007
Pfizer Healthcare Ireland
|
SPC
PIL
|
Octreotide 200 micrograms/ml solution for injection
Solution for injection
Compare
|
PA0822/218/003
Authorised: 22/06/2007
Pfizer Healthcare Ireland
|
SPC
PIL
|
Octreotide 50 micrograms/1 ml solution for injection
Solution for injection
Compare
|
PA0822/218/001
Authorised: 22/06/2007
Pfizer Healthcare Ireland
|
SPC
PIL
|
Octreotide 500 micrograms/1 ml solution for injection
Solution for injection
Compare
|
PA0822/218/004
Authorised: 22/06/2007
Pfizer Healthcare Ireland
|
SPC
PIL
|
Odefsey
Film-coated tablet
Compare
|
EU/1/16/1112/001-002
Gilead Sciences Ireland UC
|
SPC
PIL
IPAR
|
Odomzo
Capsule, hard
Compare
|
EU/1/15/1030/001-002
Authorised: 14/08/2015
Sun Pharmaceutical Industries Europe B.V.
|
SPC
PIL
IPAR
|
Odrik 1mg Hard Capsules
Capsule, hard
Compare
|
PA2010/005/002
Authorised: 25/11/1992
Mylan IRE Healthcare Limited
|
SPC
PIL
|
Odrik 2mg Hard Capsules
Capsule, hard
Compare
|
PA2010/005/003
Authorised: 25/11/1992
Mylan IRE Healthcare Limited
|
SPC
PIL
|